Trifluoroacetic acid → Methyl 3-benzyloxy-5-[3-[[2-(4-chlorophenyl)-4-methylthiazol-5-yl]carbonylamino]piperidin-1-yl]benzoate

HRID 602205Notes

Reaction equation

HRID 602205 reaction equation
[CH2:1]([O:8][C:9]1[CH:10]=[C:11]([CH:16]=[C:17]([N:19]2[CH2:24][CH2:23][CH2:22][CH:21]([NH:25]C(OC(C)(C)C)=O)[CH2:20]2)[CH:18]=1)[C:12]([O:14][CH3:15])=[O:13])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.FC(F)(F)C(O)=O.[Cl:40][C:41]1[CH:46]=[CH:45][C:44]([C:47]2[S:48][C:49]([C:53]([OH:55])=O)=[C:50]([CH3:52])[N:51]=2)=[CH:43][CH:42]=1.O.ON1C2C=CC=CC=2N=N1.CN1CCOCC1.Cl.CN(C)CCCN=C=NCC>ClCCl.C(OCC)(=O)C>[CH2:1]([O:8][C:9]1[CH:10]=[C:11]([CH:16]=[C:17]([N:19]2[CH2:24][CH2:23][CH2:22][CH:21]([NH:25][C:53]([C:49]3[S:48][C:47]([C:44]4[CH:43]=[CH:42][C:41]([Cl:40])=[CH:46][CH:45]=4)=[N:51][C:50]=3[CH3:52])=[O:55])[CH2:20]2)[CH:18]=1)[C:12]([O:14][CH3:15])=[O:13])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

Participants

9

Conditions

Temperature
0 °C

Procedure

Methyl 3-benzyloxy-5-(3-tert-butoxycarbonylaminopiperidin-1-yl)benzoate (23.0 mg, 0.0522 mmol) was dissolved in anhydrous dichloromethane (0.5 mL). While this solution is chilled in an ice bath and stirred, trifluoroacetic acid (80 μL, 6.82 mmol) was added and the reaction mixture was stirred for 2 hours. Subsequently, the mixture was concentrated and a 10% hydrochloric acid/methanol solution (1.5 mL) was added to the residue. The mixture was then stirred at room temperature for 1 hour and was concentrated. The same process was repeated 3 times and the resulting solid were washed with ethyl acetate. This gave 20.9 mg of a blown powder. This product (19.8 mg) was dissolved in N,N-dimethylformamide (1 mL). While the solution was chilled to 0° C. and stirred, 2-(4-chlorophenyl)-4-methylthiazole-5-carboxylic acid (15.5 mg, 0.0611 mmol), 1-hydroxybenzotriazole monohydrate (8.8 mg, 0.0575 mmol), N-methylmorpholine (17 μL, 0.155 mmol) and 3-(3-dimethylaminopropyl)-1-ethylcarbodiimide hydrochloride (11.7 mg, 0.0610 mmol) were added and the mixture was stirred for 20 min. The reaction mixture was further stirred at room temperature for the subsequent 6 hours. Subsequently, the mixture was diluted with ethyl acetate and the organic layer washed sequentially with 5% aqueous citric acid, a saturated aqueous sodium bicarbonate solution, water and brine. The washed product was then dried over anhydrous sodium sulfate and was concentrated. Purification of the resulting residue by silica gel column chromatography (hexane:ethyl acetate=4:1) gave 22.8 mg (75%) of the desired compound as a colorless powder.

Workup

  1. temperatureWhile this solution is chilled in an ice bath
  2. stirringthe reaction mixture was stirred for 2 hours
  3. concentrationSubsequently, the mixture was concentrated
  4. additiona 10% hydrochloric acid/methanol solution (1.5 mL) was added to the residue
  5. stirringThe mixture was then stirred at room temperature for 1 hour
  6. concentrationwas concentrated
  7. washthe resulting solid were washed with ethyl acetate
  8. dissolutionThis product (19.8 mg) was dissolved in N,N-dimethylformamide (1 mL)
  9. stirringstirred
  10. stirringthe mixture was stirred for 20 min
  11. stirringThe reaction mixture was further stirred at room temperature for the subsequent 6 hours
  12. washthe organic layer washed sequentially with 5% aqueous citric acid
  13. dry with materialThe washed product was then dried over anhydrous sodium sulfate
  14. concentrationwas concentrated
  15. customPurification of the resulting residue by silica gel column chromatography (hexane:ethyl acetate=4:1)

Sources & evidence

ORD record
ord-376fa7834c564599a70875fc0154303c
Source dataset
uspto-grants-2011_03
Patent number
US07902367B2

Reaction notes

Loading…